miR-378a-5p targets FGR to suppress proliferation, invasion and migration in lung adenocarcinoma cells.

IF 1.7 4区 医学 Q4 ONCOLOGY
Translational cancer research Pub Date : 2025-08-31 Epub Date: 2025-08-28 DOI:10.21037/tcr-2025-13
Yali Zhang, Tingting Bian, Runfeng Yang, Qi Zheng, Jianguo Zhang, Yifei Liu, Lihua Gao
{"title":"miR-378a-5p targets FGR to suppress proliferation, invasion and migration in lung adenocarcinoma cells.","authors":"Yali Zhang, Tingting Bian, Runfeng Yang, Qi Zheng, Jianguo Zhang, Yifei Liu, Lihua Gao","doi":"10.21037/tcr-2025-13","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Lung cancer (LC) remains the leading cause of cancer-related mortality worldwide. Emerging evidence demonstrates that microRNAs (miRNAs) serve as crucial post-transcriptional regulators in lung carcinogenesis. Previous studies have identified aberrant expression of miR-378a-5p in non-small cell lung cancer (NSCLC), although its precise regulatory mechanisms remain to be fully elucidated. This study aimed to investigate the mechanisms by which miR-378a-5p leads to the onset and progression of lung adenocarcinoma (LUAD).</p><p><strong>Methods: </strong>LUAD's miR-378a-5p expression levels were examined utilizing publicly accessible databases. Quantitative real-time fluorescence polymerase chain reaction (qRT-PCR) was used to measure the expression of miR-378a-5p in LUAD tissues and nearby normal tissues from the Affiliated Hospital of Nantong University. Additionally, A549 and H1299 cells were transfected with miR-378a-5p mimics and inhibitor, and the role of miR-378a-5p in cell proliferation, migration and invasion was evaluated by Cell Counting Kit-8 (CCK-8) assay, colony formation assay, wound healing assay and transwell assay. The downstream target genes of miR-378a-5p were predicted using the microCosm database. Subsequently, the differentially expressed genes between the high and low expression groups of miR-378a-5p were subjected to enrichment analysis. The related pathways were identified, and the corresponding pathway-related genes were retrieved from the MsigDB website. The intersection of these genes was analyzed, leading to the identification of FGR proto-oncogene, Src family tyrosine kinase (FGR) as a potential downstream target gene. The expression level of FGR in LUAD was analyzed using the UALCAN database, and the correlation between FGR expression and various clinicopathological parameters was assessed. Immune infiltration analysis was performed based on the gene expression profiles of LUAD from The Cancer Genome Atlas (TCGA).</p><p><strong>Results: </strong>It was discovered that LUAD tissues had downregulated miR-378a-5p. The miR-378a-5p inhibitor facilitated the proliferation, invasion, and migration, but the overexpression of miR-378a-5p turned out to limit these processes in both cell lines. Bioinformatics analysis identified FGR as a gene that miR-378a-5p targeted, with a positive correlation between their expression levels. Individuals with LUAD with low FGR expression had a poor prognosis, based upon research results of an analysis of the TCGA database. Furthermore, multivariate Cox regression analysis demonstrated that FGR was an independent prognostic factor for LUAD. According to the UALCAN database, FGR was revealed to be under expressed in LUAD tissues and to be substantially correlated with T stage. Furthermore, there were notable variations in the quantity of different immune categories of cells between the groups with high and low FGR expression.</p><p><strong>Conclusions: </strong>By targeting FGR, miR-378a-5p prevents LUAD cell invasion, migration and proliferation.</p>","PeriodicalId":23216,"journal":{"name":"Translational cancer research","volume":"14 8","pages":"4920-4938"},"PeriodicalIF":1.7000,"publicationDate":"2025-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12432781/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tcr-2025-13","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/28 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Lung cancer (LC) remains the leading cause of cancer-related mortality worldwide. Emerging evidence demonstrates that microRNAs (miRNAs) serve as crucial post-transcriptional regulators in lung carcinogenesis. Previous studies have identified aberrant expression of miR-378a-5p in non-small cell lung cancer (NSCLC), although its precise regulatory mechanisms remain to be fully elucidated. This study aimed to investigate the mechanisms by which miR-378a-5p leads to the onset and progression of lung adenocarcinoma (LUAD).

Methods: LUAD's miR-378a-5p expression levels were examined utilizing publicly accessible databases. Quantitative real-time fluorescence polymerase chain reaction (qRT-PCR) was used to measure the expression of miR-378a-5p in LUAD tissues and nearby normal tissues from the Affiliated Hospital of Nantong University. Additionally, A549 and H1299 cells were transfected with miR-378a-5p mimics and inhibitor, and the role of miR-378a-5p in cell proliferation, migration and invasion was evaluated by Cell Counting Kit-8 (CCK-8) assay, colony formation assay, wound healing assay and transwell assay. The downstream target genes of miR-378a-5p were predicted using the microCosm database. Subsequently, the differentially expressed genes between the high and low expression groups of miR-378a-5p were subjected to enrichment analysis. The related pathways were identified, and the corresponding pathway-related genes were retrieved from the MsigDB website. The intersection of these genes was analyzed, leading to the identification of FGR proto-oncogene, Src family tyrosine kinase (FGR) as a potential downstream target gene. The expression level of FGR in LUAD was analyzed using the UALCAN database, and the correlation between FGR expression and various clinicopathological parameters was assessed. Immune infiltration analysis was performed based on the gene expression profiles of LUAD from The Cancer Genome Atlas (TCGA).

Results: It was discovered that LUAD tissues had downregulated miR-378a-5p. The miR-378a-5p inhibitor facilitated the proliferation, invasion, and migration, but the overexpression of miR-378a-5p turned out to limit these processes in both cell lines. Bioinformatics analysis identified FGR as a gene that miR-378a-5p targeted, with a positive correlation between their expression levels. Individuals with LUAD with low FGR expression had a poor prognosis, based upon research results of an analysis of the TCGA database. Furthermore, multivariate Cox regression analysis demonstrated that FGR was an independent prognostic factor for LUAD. According to the UALCAN database, FGR was revealed to be under expressed in LUAD tissues and to be substantially correlated with T stage. Furthermore, there were notable variations in the quantity of different immune categories of cells between the groups with high and low FGR expression.

Conclusions: By targeting FGR, miR-378a-5p prevents LUAD cell invasion, migration and proliferation.

Abstract Image

Abstract Image

Abstract Image

miR-378a-5p靶向FGR抑制肺腺癌细胞的增殖、侵袭和迁移。
背景:肺癌(LC)仍然是世界范围内癌症相关死亡的主要原因。新出现的证据表明,microRNAs (miRNAs)在肺癌发生过程中起着至关重要的转录后调节作用。先前的研究已经发现了miR-378a-5p在非小细胞肺癌(NSCLC)中的异常表达,尽管其精确的调控机制仍有待充分阐明。本研究旨在探讨miR-378a-5p导致肺腺癌(LUAD)发生和发展的机制。方法:利用可公开访问的数据库检测LUAD的miR-378a-5p表达水平。采用定量实时荧光聚合酶链反应(qRT-PCR)检测miR-378a-5p在南通大学附属医院LUAD组织及附近正常组织中的表达。此外,用miR-378a-5p模拟物和抑制剂转染A549和H1299细胞,并通过细胞计数试剂盒-8 (CCK-8)试验、菌落形成试验、伤口愈合试验和transwell试验评估miR-378a-5p在细胞增殖、迁移和侵袭中的作用。使用microcosmos数据库预测miR-378a-5p的下游靶基因。随后,对miR-378a-5p高、低表达组之间的差异表达基因进行富集分析。鉴定出相关通路,并从MsigDB网站检索相应通路相关基因。通过分析这些基因的交集,确定了FGR原癌基因Src家族酪氨酸激酶(FGR)作为潜在的下游靶基因。使用UALCAN数据库分析FGR在LUAD中的表达水平,并评估FGR表达与各种临床病理参数的相关性。基于癌症基因组图谱(TCGA)中的LUAD基因表达谱进行免疫浸润分析。结果:发现LUAD组织下调miR-378a-5p。miR-378a-5p抑制剂促进了增殖、侵袭和迁移,但miR-378a-5p的过表达在两种细胞系中都限制了这些过程。生物信息学分析发现,FGR是miR-378a-5p靶向的基因,二者表达水平呈正相关。根据TCGA数据库分析的研究结果,FGR低表达的LUAD患者预后较差。此外,多变量Cox回归分析显示FGR是LUAD的独立预后因素。根据UALCAN数据库,FGR在LUAD组织中表达不足,并与T期密切相关。FGR高表达组和低表达组不同免疫类型细胞的数量也有显著差异。结论:miR-378a-5p通过靶向FGR抑制LUAD细胞的侵袭、迁移和增殖。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
252
期刊介绍: Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients'' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信